Skip to content

Clinical trials

Completed Phase 1 Parasomnias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 1 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20121
20131
20171
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline1
Massachusetts General Hospital1
National Human Genome Research Institute (NHGRI)1
Neurim Pharmaceuticals Ltd.1
Northwell Health1
University of California, Los Angeles1
University of California, San Francisco1
University of Massachusetts, Amherst1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias8
Sleep Initiation and Maintenance Disorders2
Smith-Magenis Syndrome2
Angelman Syndrome1
Autism Spectrum Disorder1
Chromosome Deletion1
Developmental Disabilities1
Inflammation1
Intellectual Disability1
Postoperative Complications1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.